Latest
Headlines
Newsletter
Newsletter
Sign In
Home
Sign In
Sign In
Home
News
Berita
Business
Lifestyle
Opinion
World
Sports
Videos
Property
Education
Carzilla
Gallery
Accelerator
Home
News
Malaysia
Borneo+
Berita
Tempatan
Pandangan
Dunia
Business
Local Business
World Business
Lifestyle
Everyday Heroes
Travel
Food
Entertainment
Money
Health & Family
Pets
Tech
Automotive
Opinion
Column
Editorial
Letters
FMT Worldviews
World
Southeast Asia
Sports
Football
Badminton
Motorsports
Tennis
Videos
Property
Education
Carzilla
Gallery
Accelerator
J & J
BUSINESS
J&J begins crucial battle over US$10bil baby powder settlement
BUSINESS
J&J tops quarterly profit estimates on cancer drug sales
BUSINESS
J&J lifts profit and sales forecasts, beats Wall Street expectations
BUSINESS
J&J advances US$6.475bil settlement of talc cancer lawsuits
DUNIA
J&J diarah bayar USD18.8 juta kepada pesakit kanser California
BUSINESS
J&J’s US$8.9bil talc settlement faces US bankruptcy test
BUSINESS
J&J to end global sales of talcum-based baby powder
WORLD
US limits use of J&J’s Covid vaccine on blood clot risks
BUSINESS
J&J to suspend supply of personal care products to Russia
WORLD
Japan to accept J&J Covid jab for border entry
BUSINESS
J&J expects Covid vaccine sales to jump as much as 46% in 2022
WORLD
J&J booster 85% effective against Omicron hospitalisation
WORLD
J&J booster 84% effective against hospitalisations, study finds
WORLD
US experts tout mRNA Covid vaccines over J&J shot
BUSINESS
Drugmakers beat US$50 bil opioid case in first industry win
WORLD
US CDC signs off on Moderna, J&J ‘mix and match’ boosters
WORLD
CDC backs J&J shot’s benefits despite neurological illness reports
SOUTH EAST ASIA
US ships over 3.2 million J&J Covid shots to Philippines
WORLD
US warns of ‘increased’ rare nerve disorder risk after J&J shot
WORLD
EU regulator finds link between heart inflammation and mRNA Covid vaccines
WORLD
US greenlights J&J vaccines produced by problem-plagued factory
WORLD
J&J scraps India vaccine trial, opting to accelerate its availability instead
BUSINESS
J&J to stop selling opioids in US, reaches US$230 mil settlement with NY
WORLD
In bid to boost supply, EU approves production site for J&J jabs in Italy
View More